REGENERX BIOPHARMACEUTICALS INC Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q1 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Regenerx Biopharmaceuticals Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q1 2023.
  • Regenerx Biopharmaceuticals Inc Entity Common Stock, Shares Outstanding for the quarter ending March 17, 2023 was 144M shares, unchanged year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 144M 0 0% Mar 17, 2023 10-K 2023-04-11
Q3 2022 144M 0 0% Nov 8, 2022 10-Q 2022-11-14
Q2 2022 144M +103K +0.07% Aug 8, 2022 10-Q 2022-08-12
Q1 2022 144M +10M +7.49% Mar 18, 2022 10-K 2022-03-30
Q3 2021 144M +10.1M +7.58% Nov 10, 2021 10-Q 2021-11-15
Q2 2021 143M +10M +7.5% Aug 2, 2021 10-Q 2021-08-06
Q1 2021 134M +105K +0.08% Feb 25, 2021 10-K 2021-03-02
Q3 2020 133M +1.94M +1.47% Nov 10, 2020 10-Q 2020-11-13
Q2 2020 133M +1.94M +1.47% Aug 7, 2020 10-Q 2020-08-14
Q1 2020 133M +3.86M +2.98% Mar 10, 2020 10-K 2020-03-20
Q3 2019 132M +3.07M +2.39% Nov 7, 2019 10-Q 2019-11-14
Q2 2019 132M +9.78M +8.03% Aug 7, 2019 10-Q 2019-08-14
Q1 2019 130M +14.6M +12.7% Mar 15, 2019 10-K 2019-03-29
Q3 2018 128M +18.6M +17% Nov 14, 2018 10-Q 2018-11-14
Q2 2018 122M Aug 7, 2018 10-Q 2018-08-09
Q1 2018 115M +8.15M +7.63% Mar 23, 2018 10-K 2018-03-29
Q3 2017 110M +3M +2.81% Nov 10, 2017 10-Q 2017-11-14
Q1 2017 107M +5.15M +5.06% Mar 24, 2017 10-K 2017-03-29
Q3 2016 107M +5.15M +5.06% Nov 11, 2016 10-Q 2016-11-14
Q2 2016 107M +5.15M +5.06% Aug 11, 2016 10-Q 2016-08-22
Q1 2016 102M +324K +0.32% Mar 25, 2016 10-K 2016-04-11
Q3 2015 102M +324K +0.32% Nov 13, 2015 10-Q 2015-11-13
Q2 2015 102M +8.66M +9.31% Aug 14, 2015 10-Q 2015-08-14
Q1 2015 101M +8.33M +8.96% Mar 27, 2015 10-K 2015-03-31
Q3 2014 101M +19.6M +24% Nov 7, 2014 10-Q 2014-11-10
Q2 2014 93M +11.3M +13.8% Aug 14, 2014 10-Q 2014-08-14
Q1 2014 93M +11.3M +13.8% Mar 28, 2014 10-K 2014-04-04
Q3 2013 81.7M 0 0% Nov 14, 2013 10-Q 2013-11-18
Q2 2013 81.7M 0 0% Aug 14, 2013 10-Q 2013-08-14
Q1 2013 81.7M +343K +0.42% Apr 11, 2013 10-K 2013-04-16
Q3 2012 81.7M +545K +0.67% Nov 14, 2012 10-Q 2012-11-14
Q2 2012 81.7M +1.77M +2.22% Aug 14, 2012 10-Q 2012-08-14
Q1 2012 81.4M Apr 3, 2012 10-K 2012-04-04
Q3 2011 81.2M Nov 11, 2011 10-Q 2011-11-14
Q2 2011 80M Aug 4, 2011 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.